Nxera Pharma Co.,Ltd.Nxera Pharma Co.,Ltd.Nxera Pharma Co.,Ltd.

Nxera Pharma Co.,Ltd.

No trades
See on Supercharts

Price target

13.990.00 0.00%
The 9 analysts offering 1 year price forecasts for SOLTF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to SOLTF in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SOLTF EPS for the last quarter is −0.02 USD despite the estimation of 0.03 USD. In the next quarter EPS is expected to reach 0.12 USD. Track more of Nxera Pharma Co.,Ltd. financials and stay on top of what is up with the company.
In the next quarter Nxera Pharma Co.,Ltd. revenue is expected to reach ‪67.01 M‬ USD. Check out Nxera Pharma Co.,Ltd. revenue and earnings and make informed decisions.
According to analysts, SOLTF price target is 13.99 USD with a max estimate of 25.06 USD and a min estimate of 9.64 USD. Check if this forecast comes true in a year, meanwhile watch Nxera Pharma Co.,Ltd. stock price chart and keep track of the current situation with SOLTF news and stock market news.
We've gathered opinions of 9 analysts rating SOLTF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.